BioSpace News Archive

Synergistic, clean-label botanical low-dose formulation also available in organic option

Nabsys, the pioneer in high-definition genome mapping, announced that it has closed on a $21 million equity round led by Hitachi High-Technologies Corporation.

Management will host its third quarter 2019 conference call on Monday, November 11, 2019 to provide a corporate update and review the Company’s poster presentations from SITC

Top shareholders of Immunovant post-closing to include Roivant Sciences and blue-chip biotech investors, including RTW Investments, BVF Partners, Adage Capital Management, Cormorant Asset Management, Eventide Asset Management, and Perceptive Advisors

Bruker announced the acquisition of the Magnettech EPR business from Freiberg Instruments GmbH, and the establishment of a related, long-term EPR supply partnership with Freiberg Instruments. Financial details of the transaction were not disclosed.

Kindred Biosciences, Inc. announced the closing of a $50 million senior secured debt facility with investment affiliates managed by Solar Capital Partners, LLC.

Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company addressing key mechanisms of tumor drug resistance, today announced that it has appointed Matthew L. Sherman, M.D. as Executive Vice President and Chief Medical Officer

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced data presentations regarding two of its wholly owned prophylactic mRNA vaccines at IDWeek in Washington, D.C.

ArQule, Inc. (Nasdaq: ARQL), today announced that the first patient was dosed in the registrational MOSAIC (Miransertib in Overgrowth Syndromes in Adults and Children) trial of its oral, selective pan-AKT inhibitor, miransertib, for the treatment of Proteus syndrome (PS) and PIK3CA-related Overgrowth Spectrum disorders (PROS).

Highly Complementary Portfolio of Ultrasound and Radiopharmaceutical Diagnostics and Oncology Therapeutics